Form 4 for LH Labcorp
Accepted 2026-02-10 00:00:00 ET · period of report 2026-02-06 · accession 0000920148-26-000033 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-02-10 | 2026-02-06+ | LH | Caveney Brian J | EVP, CMO, CSO, Pres of ED | M - OptEx | — | +1,298 | 31.1K | +4% | — |
| DM | 2026-02-10 | 2026-02-06+ | LH | Caveney Brian J | EVP, CMO, CSO, Pres of ED | F - Tax | $275.72 | -389 | 31.1K | -1% | -$107.3K |
| DM | 2026-02-10 | 2026-02-06+ | LH | Caveney Brian J | EVP, CMO, CSO, Pres of ED | M - OptEx | $0.00 | -1,298 | 2,890 | -31% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-06 | M | A | 670 | — | 30,838.92 | D | — | — | (F1) Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. (F2) Amount includes 57.1306 shares acquired on June 30, 2025 under the Labcorp Holdings Inc. Amended and Restated 2016 Employee Stock Purchase Plan and 45.1355 shares acquired on December 31, 2025 under the Labcorp Holdings Inc. 2025 Employee Stock Purchase Plan. |
| 2 | Common | Common Stock | 2026-02-06 | F | D | 209 | $277.20 | 30,629.92 | D | — | — | |
| 3 | Common | Common Stock | 2026-02-09 | F | D | 32 | $274.01 | 31,077.92 | D | — | — | |
| 4 | Common | Common Stock | 2026-02-07 | M | A | 111 | — | 31,257.92 | D | — | — | (F1) Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. |
| 5 | Common | Common Stock | 2026-02-09 | F | D | 148 | $274.01 | 31,109.92 | D | — | — | |
| 6 | Common | Common Stock | 2026-02-07 | M | A | 517 | — | 31,146.92 | D | — | — | (F1) Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. |
| 7 | Derivative | Restricted Stock Unit | 2026-02-06 | M | D | 670 | $0.00 | 3,518 | D | — · — to — | 670 Common Stock | (F5) This number reflects the aggregate number of Restricted Stock Units held by the reporting person. (F1) Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. (F4) The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 6, 2025. |
| 8 | Derivative | Restricted Stock Unit | 2026-02-07 | M | D | 517 | $0.00 | 3,001 | D | — · — to — | 517 Common Stock | (F5) This number reflects the aggregate number of Restricted Stock Units held by the reporting person. (F1) Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. (F6) The Restricted Stock Units vested in three equal annual installments beginning on February 7, 2024 and are now fully vested. |
| 9 | Derivative | Restricted Stock Unit | 2026-02-07 | M | D | 111 | $0.00 | 2,890 | D | — · — to — | 111 Common Stock | (F5) This number reflects the aggregate number of Restricted Stock Units held by the reporting person. (F1) Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. (F6) The Restricted Stock Units vested in three equal annual installments beginning on February 7, 2024 and are now fully vested. |